Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

693
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
693
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

647
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
647
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

426
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
426
Hydrolysis01:15

Hydrolysis

124.3K
Overview
Hydrolysis is a chemical reaction in which the addition of water breaks down a polymer into its simpler monomer units. For example, peptides break into amino acids, carbohydrates into simple sugars, and DNA into nucleotides. Enzymes often facilitate these processes.
Hydrolysis Reverses Dehydration Synthesis
Complex carbohydrates can be broken down by breaking the bonds between individual sugar units. The reaction breaks a glycosidic bond as water is added to the compound. The...
124.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

313
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313
Composition of Body Fluids01:29

Composition of Body Fluids

3.0K
Water functions as a solvent accommodating various solutes, which can be categorized under electrolytes and non-electrolytes. Non-electrolytes are usually held together by covalent bonds, restricting them from dissociating in solution, thereby leading to a lack of electrically charged components upon dissolving in water. They are predominantly organic molecules, such as glucose, creatinine, and urea. Electrolytes, on the other hand, are compounds that can break down into ions in water.
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunonutrition in Early Life: The Role of Complementary Feeding, Dietary Patterns, and Nutritional Exposures on the Health of Young Children-An EAACI Scoping Review.

Allergy·2026
Same author

Pharmacokinetics and pharmacodynamics of AQST-109 sublingual film in oral allergy syndrome: A phase 2 study.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Erratum to "World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update - IV - A quality appraisal with the AGREE II instrument" [World Allergy Organ J 15(2) (February 2022) 100613].

The World Allergy Organization journal·2026
Same author

Emollient Formulations and Skin Barrier Practices in the Context of Eczema and Food Allergy Prevention.

Allergy·2026
Same author

Nutritional, growth, and microbiome implications of oral immunotherapy: Unintended consequences and clinical considerations.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Low risk of ocular toxicity following topical ocular administration of epinephrine nasal spray: implications for unintentional exposure.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Chairpersons, Speakers and Contributors.

Nestle Nutrition Institute workshop series·2024
Same journal

Integrating Next-Generation Evidence-Based Medicine Into Clinical Studies on Gut Microbiota Modulation.

Nestle Nutrition Institute workshop series·2024
Same journal

The Art of Chewing: Optimizing Early Life Sensory Exposure to Develop Healthy Eating Behavior.

Nestle Nutrition Institute workshop series·2024
Same journal

What Does Healthy Microbiome Development Look Like? State of the Art and Beyond.

Nestle Nutrition Institute workshop series·2024
Same journal

Strategies to Develop Balanced Dietary Habits: Solving the Dilemma.

Nestle Nutrition Institute workshop series·2024
Same journal

Understanding the Ovarian Clock - Essential Knowledge for Pediatricians.

Nestle Nutrition Institute workshop series·2024
See all related articles

Related Experiment Video

Updated: Mar 19, 2026

Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings
04:16

Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings

Published on: February 7, 2025

983

Hydrolyzed Formula for Every Infant?

David M Fleischer, Carina Venter, Yvan Vandenplas

    Nestle Nutrition Institute Workshop Series
    |June 24, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Hydrolyzed formulas (HF) are increasingly used, but evidence for their benefit in all infants is limited. Long-term studies are needed to determine if HF is optimal for healthy, standard-risk infants.

    More Related Videos

    Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
    09:36

    Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers

    Published on: July 28, 2022

    2.7K
    Recapitulating Suckling-to-Weaning Transition In Vitro using Fetal Intestinal Organoids
    08:15

    Recapitulating Suckling-to-Weaning Transition In Vitro using Fetal Intestinal Organoids

    Published on: November 15, 2019

    6.5K

    Related Experiment Videos

    Last Updated: Mar 19, 2026

    Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings
    04:16

    Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings

    Published on: February 7, 2025

    983
    Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
    09:36

    Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers

    Published on: July 28, 2022

    2.7K
    Recapitulating Suckling-to-Weaning Transition In Vitro using Fetal Intestinal Organoids
    08:15

    Recapitulating Suckling-to-Weaning Transition In Vitro using Fetal Intestinal Organoids

    Published on: November 15, 2019

    6.5K

    Area of Science:

    • Pediatrics
    • Nutrition Science
    • Allergy Research

    Background:

    • Hydrolyzed formulas (HF) are used for specific infant populations, including those with cow's milk allergy and for allergy prevention.
    • There is increasing global use of HF, raising questions about their suitability for all standard-risk infants not exclusively breastfed.

    Purpose of the Study:

    • To evaluate the current evidence regarding the nutritional adequacy and long-term growth outcomes of modern hydrolyzed formulas (HF) compared to intact protein formulas (IPF).
    • To assess the available data on the efficacy of HF in preventing atopic dermatitis (AD) and compare it with breastfeeding and IPF.
    • To determine if HF can be recommended as an optimal choice for all standard-risk, full-term, non-exclusively breastfed infants.

    Main Methods:

    • Systematic review of existing literature and meta-analyses on formula consumption and infant health outcomes.
    • Analysis of data on nutritional adequacy and growth patterns in infants fed HF versus IPF.
    • Consideration of cost-effectiveness and limitations of current studies.

    Main Results:

    • Limited long-term data exists on the growth of infants fed HF compared to IPF.
    • Meta-analyses suggest a potential lower risk of atopic dermatitis (AD) with partially hydrolyzed formulas (pHF) versus IPF, but with significant study limitations.
    • Cost comparisons of HF globally are difficult due to price variations.

    Conclusions:

    • Current scientific evidence does not support the routine use of HF as an equivalent option to breastfeeding or IPF for all healthy, standard-risk infants.
    • More long-term studies are required to investigate the feasibility and benefits of HF as a routine feeding option.
    • Recommendations for widespread HF use must be carefully balanced against the limited available data and potential overstatement of benefits.